premium content
Sosandar Interims: Profit (Just) But Negative Cashflow
AIM-listed online ladies fashionwear purveyor Sosandar (SOS) released its interim results to September 2022 yesterday morning. The announcement was laced with good news: revenue growth of 72% and a profit being two, but the cashflow statement tells a different story and revenue growth has slowed substantially – the last not a surprise, given the poor economic outlook of UK plc.- By Nigel Somerville, the Deputy Sheriff of AIM |
- 14 December 2022, 08:34 |
Blackbird Flies Further Forward in World TV's Great Race
Hello Share Collectors. When I worked in TV we had to put our film on trains to be collected by motorcyclists and rushed to the studio labs to be developed. Of course, this meant news was late reaching the viewer. How things have changed. And leading the charge is a British company called Blackbird (BIRD).- By Malcolm Stacey |
- 14 December 2022, 08:12 |
premium content
Triad Group – interims, second half “strong upturn”?
UK technology consultancy group Triad (TRD) has announced admitted “disappointing” results for its half-year ended 30th September 2022 but is “delighted to say that the beginning of our second half year has seen a strong upturn in levels of new business wins and bidding activity”.- By HotStockRockets |
- 13 December 2022, 16:27 |
Image Scan – full-year results, “a strong operational and financial platform”… or not?
Previously writing on x-ray imaging company Image Scan (IGE), in October as the shares fell towards 1p I concluded that with the outlook and a now down to below £1.5 million market cap, the balance sheet should be reviewed closely on the full-year to 30th September results announcement… continue to avoid. With the shares last closing at 0.925p, the company has today announced those results.
- By Steve Moore |
- 13 December 2022, 16:17 |
premium content
Tom Winnifrith Bearcast: after the funding time to close the Shield Therapeutics short?
he Greek Hovel olive harvest is done and I am soon off to the press. Phew. In today's podcast I discuss Shield Therapeutics (STX), FinnCap (FCAP) and Argo Blockchain (ARB)- By Tom Winnifrith |
- 13 December 2022, 15:52 |
premium content
Forget wanting to get some how’s your father the reason Sam Smith walked from FinnCap – atrocious results!
On 21 June smug and conceited Sam Smith announced that she was stepping down as CEO of FinnCrap (FCAP) the business she had founded and floated at 27p just three years ago. She left the business on September 28 and, according to one of the sycophantic journalists who have blown smoke up Smith’s arse for being a wonderwoman in a man’s world, yadda, yadda, yadda, this was so she could find time for a bit of How’s Your Father. Whatever. The real reason Smith walked was that she must have been aware just how dire trading was. Today we have results for the6 months to 30 September and they are catastrophic.- By Tom Winnifrith, the Sheriff of AIM |
- 13 December 2022, 15:08 |
premium content
Victoria plc – The Signs are There!
I have just finished reading Tim Steer’s excellent book, The Signs Were There (The clues for investors that a company is heading for a fall), which I thoroughly recommend. It contains chapters on many old favourites such as Connaught, Quindell/Slater & Gordon, Autonomy, Carillion and the Woodford Equity Income Fund. I hope that the book will be updated in the near future, and when it is I fully expect a chapter on Victoria plc (VCP).- By Lucian Miers |
- 13 December 2022, 14:34 |
Nuformix – interims, how’s the prior chaos now?
Previously writing on pharmaceutical development company Nuformix (NFX), in May with the shares falling below 0.50p I noted management chaos follows operational chaos, hopefully warnings heeded!. Co-founder and now again Executive Director Dan Gooding today though argues in half-year results, “I expect our on-going penultimate pre-clinical studies to conclude that our data and IP support the progression of the programme towards patients for whom I believe NXP002 can address both the side effect and efficacy limitations of existing IPF treatment options. We hope to announce results for both NXP002 and NX004 in the near-term”. So what of a 0.375p share price now?
- By Steve Moore |
- 13 December 2022, 14:01 |
Access Intelligence – argues “ahead of consensus expectations”… but only previously massively reduced such and what of the outlook?
Describing itself as a “technology innovator delivering Software-as-a-Service solutions for the global marketing and communications industries”, Access Intelligence (ACC) has issued a trading update commencing noting “excellent revenue growth of 97% and Adjusted EBITDA ahead of consensus expectations” and concluding that “pipeline remains strong… remains very positive about the opportunity for the company to deliver profitable growth”. So what of a current 63.5p share price…down 27.4%?!- By Steve Moore |
- 13 December 2022, 11:32 |
premium content
Argo Blockchain back from suspension, shares crash, statement is dire
So the rapidly deleted web pages from the Argo Blockchain (ARB) website, which you can see HERE, were real – it ‘fessed last night, Chapter 11 is a very real possibility. The statement will bring no comfort to the bulls bit at least it means the shares can trade again and they have duly slumped by 48% to 3.5p. That is 3.5p too high.- By Tom Winnifrith |
- 13 December 2022, 10:49 |
premium content
Capita is excited about itself (Again!)
If you go back far enough in time, Capita (CPI) was a company where some investors (not me) made a fortune during the 1990s but life has changed a lot since then. And, despite the 90% share price fall over the last five years, I have not been a fan as most recently noted three months ago. But are the glory days coming back? After all, Capita notes this morning that it “continues to perform well, with further revenue growth and a stronger balance sheet”.
- By Chris Bailey |
- 13 December 2022, 10:31 |
On behalf of Woodlarks I say thank you very much: Christmas Grotto appeal closed!
I asked you for £3,000 to fund the Woodlarks Christmas Grotto appeal a week ago. Today we have reached our target with gift aid on top. I have asked Darren to close the page when he wakes up in the socialist hell hole that is Canada (no sniggering at the back) so no more money please. Treat yourself to an extra bottle of ouzo this Christmas. On behalf of Nick Richards, his charming Mrs Sarah and all the team at Woodlarks, we are very grateful for your generosity. Thank you all.- By Tom Winnifrith |
- 12 December 2022, 16:50 |
premium content
Tom Winnifrith Bearcast: time to write to the FCA about Odey
I start with macro economics and why I am so bearish on UK PLC. Then to Purplebricks (PURP) and the housebuilders in light of today's shocking warning from the UK banks on mortgage lending prospects for 2023. Then Parsley Box (MEAL), Vast Resources (VAST) as the trap door approaches and Advanced Oncotherapy (AVO, Odey Asset Management and the FCA. I may be wrong about this but I'd like the FCA to have a butcher's. Finally a big thank you from me on helping us raise all the money needed for the Woodlarks Christmas Grotto appeal.- By Tom Winnifrith |
- 12 December 2022, 16:47 |
Kromek – “delighted” with nuclear security contracts wins, what about the balance sheet?
Kromek Group (KMK) states that it is “delighted” to have been awarded two contracts to supply European government end-users “totalling £1.5m, for the supply of its D3M and D3S-based nuclear security products. Delivery will commence immediately and the revenue will be received in Kromek's current financial year”. So what of a current share price response up approaching 8% towards 11p?- By Steve Moore |
- 12 December 2022, 16:27 |
premium content
Nanosynth just 0.3p to sell: bankruptcy by Christmas, will the misleaders come clean?
Back in August the serial deceivers at nanosynth (NNN) announced a death spiral deal with the shysters at Lanstead claiming it “is pleased to announce a conditional subscription to raise £2,942,500 through the issue of 535,000,000 new ordinary shares of 0.01 pence each in the Company at a price of 0.55 pence per Ordinary Share to institutional investor Lanstead Capital Investors L.P., together with a related sharing agreement pursuant to which the Company pledges the gross proceeds of the Lanstead Subscription.” Morons did not read or understand the small print. Now bankruptcy looms and morons who bought into that RNS should be rightly furious with the company and its advisers.- By Tom Winnifrith, the Sheriff of AIM |
- 12 December 2022, 16:05 |
premium content
Chill Brands is taking the piss, clearly out of cash a pathetic pre placing ramp, new order might cover 3 days costs
The last time we knew the cash position of Chill Brands (CHLL) was at March 31. The company neglected to give any update with its (piss poor) finals or in a trading update a few weeks ago. You can thus guess that the position is pretty dismal and the company is close to running on vapours. Hence 6 RNS ramptastic announcements since September. Today’s is the most wretched yet.- By Tom Winnifrith |
- 12 December 2022, 15:45 |
premium content
MJ Hudson Group – adjusted EBITDA even more manipulated bullshit earnings than usually?, shares suspended
Previously writing on service provider to the asset management industry specialising in private markets MJ Hudson Group (MJH), in October with the shares down to 16.5p I noted “audit adjustments” – including aren’t IT development, M&A and fundraising quite usual activities for an attempted growth business?, and that it will be interesting to see how net debt compares to £15.7 million house broker Cenkos had been forecasting. The shares last closed at 13.125p… and today “Company update and suspension of trading”!
- By Steve Moore |
- 12 December 2022, 14:40 |
premium content
Bluebird Merchant Ventures – small fundraise and opened streaming funding discussions, Buy
Bluebird Merchant Ventures (BMV) has announced it has raised £0.23 million at 2p per share and opened discussions with a streaming fund for the entire capital needed for the development of the high grade Kochang gold and silver mine.- By HotStockRockets |
- 12 December 2022, 14:40 |
Engage XR – I having questioned just how “strong” the cash position would be at year-end, the answer is… not very!
Last month I questioned on ‘Virtual reality technology company’ Engage XR (EXR) argues “a huge moment for the group”, but how “successful” is this evolution to be?, concluding with the shares up to 15p ‘I look forward to seeing just how “strong” the cash position remains at the year-end… certainly at this juncture, avoid / sell’. The shares last closed at 13p…and today a “trading update” and they’re now plummeting.
- By Steve Moore |
- 12 December 2022, 11:55 |
premium content
Advanced Oncotherapy – Scraping The Barrel - what is Crispin Odey doing with his client's cash?: SELL
AIM-listed Advanced Oncotherapy (AVO) has announced that it has raised another £1.5 million from an existing institutional investor at 25p per share, the par price below which the law prevents the issue of confetti. With the stock having closed last week at just 16.75p, this is surely pure madness on the part of that institutional investor – who we are reliably told is none other than Crispin Odey. How his compliance officer is allowing this, heaven only knows.- By Nigel Somerville, the Deputy Sheriff of AIM |
- 12 December 2022, 10:27 |